Clinical Trials Logo

Hyperthyroidism clinical trials

View clinical trials related to Hyperthyroidism.

Filter by:

NCT ID: NCT02005250 Completed - Hypothyroidism Clinical Trials

Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism

Start date: February 2012
Phase:
Study type: Observational

The aim to evaluate the bone structure by Dexa-scan, extreme CT and bone markers before and one year after treatment for a thyroid functional disorder

NCT ID: NCT01789541 Completed - Atrial Fibrillation Clinical Trials

Is a Low Thyreotropin Level Predictive of Recurrent Arrhythmia After Catheter Ablative Surgery?

TABLAS
Start date: February 2013
Phase: N/A
Study type: Observational

Overt hyperthyroidism (so-called "goiter" in lay language) is a hormonal disturbance that is known to increase the risk of atrial fibrillation (a common heart arrhythmia with potentially severe consequences) in some patients. Previous research has indicated that even slight elevations in thyroid hormone levels - so called subclinical hyperthyroidism - may increase this risk. When atrial fibrillation and overt hyperthyroidism are found simultaneously in a patient, the hormonal imbalance must be treated first in order to later resolve the arrhythmia. It is unclear whether this strategy holds true for subclinical hyperthyroidism. Our two hypotheses are: 1) Subclinical hyperthyroidism is more prevalent in patients admitted for atrial fibrillation ablation than in the population as a whole, and 2) Patients with subclinical hyperthyroidism and atrial fibrillation benefit less from ablation than others. As a control group, we have chosen patients admitted for ablation of AV-nodal Reentry Tachycardia at the same clinics as the cases. No correlation has ever been shown between AV-nodal Reentry Tachycardia and hyperthyroidism.

NCT ID: NCT01727973 Completed - Autoimmune Diseases Clinical Trials

Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy

Start date: October 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to evaluate the effects of subantimicrobial dose doxycycline (50 mg/d), administered for 12 wk, for patients with active moderate-severe Graves' Orbitopathy (GO).

NCT ID: NCT01528904 Completed - Clinical trials for Hypothyroidism in Pregnancy

Maternal Autoimmune Thyroid Disease and Fetal Thyroxin

Start date: January 2001
Phase: N/A
Study type: Observational

The purpose of this trial is to correlate fetal thyroid hormones from fetal cord blood with clinical (maternal antithyroid drug dose and antithyroid antibodies) and ultrasound (US) parameters of fetal thyroid function from pregnant mothers with autoimmune thyroid disease (AITD).

NCT ID: NCT01384786 Completed - Thyroid Cancer Clinical Trials

The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

Start date: October 2004
Phase: N/A
Study type: Observational

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated. The investigators have found that thyroid cancer is not overlooked.

NCT ID: NCT01306916 Completed - Hyperthyroidism Clinical Trials

Coexisting Thyroid Disease and Hyperparathyroidism

Start date: September 2004
Phase: N/A
Study type: Observational

Purpose: Prospective studies of patients with hyperparathyroidism are warranted to determine the prevalence of concurrent thyroid disease applying the current standard of pre-operative radioscintigraphic and sonographic imaging of the neck. Timely diagnosis and treatment of co-existing thyroid disease is advantageous given the well-established increased morbidity associated with a second neck exploration. The purpose of this study is to determine the prevalence and specific type of thyroid disease in patients with hyperparathyroidism, and to determine the frequency with which the presence of thyroid disease alters the treatment plan for patients with hyperparathyroidism. Research Design: This will be a prospective single arm observational study of up to 200 military health care beneficiaries over the age of 18 years with primary and secondary hyperparathyroidism scheduled to undergo parathyroid resection. Methodology: Patients will undergo standard pre-operative imaging of the neck including ultrasonography and 99mTc-sestamibi scintigraphy. An operative plan will be developed based on the information obtained from history, physical examination, laboratory studies, and imaging studies. The number and type of thyroid disease in these patients will be determined based on these non-invasive studies (Objective A). A change in the otherwise standard treatment will include those patients having partial or complete resections of their thyroid glands because: a) the patients would have undergone minimally invasive surgery if not for the results of the imaging studies, and, b) the patients who would have undergone 3 ½ gland parathyroidectomy if not for the results of the imaging studies (Objective B).

NCT ID: NCT01095341 Completed - Hyperthyroidism Clinical Trials

Postoperative Hyperthyroidism

Start date: April 2008
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the frequency and the clinical course of postoperative hyperthyroidism following surgery of tertiary hyperparathyroidism (THP) and to determine the diagnostic value of thyroglobulin in this setting.

NCT ID: NCT01039818 Completed - Graves Disease Clinical Trials

Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism

Start date: February 1997
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether higher doses of radioiodine increase treatment efficacy in severe Graves' disease.

NCT ID: NCT00946296 Completed - Graves Disease Clinical Trials

Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

Start date: April 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.

NCT ID: NCT00796913 Completed - Graves Disease Clinical Trials

Remission Induction and Sustenance in Graves' Disease 2

Start date: January 7, 2008
Phase: N/A
Study type: Interventional

ATD therapy for Graves' disease is one of the commonly used options for therapy of the hyperthyroidism. The investigators study how to optimally keep patients in remission.